Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Xenon Pharmaceuticals Inc.(XENE) | 1,144,021 | 1,161,237 | +17,216 | $45.04M | $45.52M | 7.11% | +$480.4K |
| Apogee Therapeutics Inc | 664,198 | 931,728 | +267,530 | $39.01M | $42.21M | 6.59% | +$3.19M |
| Arcellx Inc COMMON STOCK | 400,000 | 425,000 | +25,000 | $33.40M | $32.59M | 5.09% | -$810.8K |
| Alkermes plcSHS(ALKS) | 1,000,000 | 1,100,000 | +100,000 | $27.99M | $31.64M | 4.94% | +$3.65M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 1,400,000 | 1,400,000 | 0 | $25.23M | $30.86M | 4.82% | +$5.63M |
| Verona Pharma PlcADS | 650,000 | 660,000 | +10,000 | $18.70M | $30.65M | 4.79% | +$11.95M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 100,000 | 82,500 | -17,500 | $21.22M | $25.46M | 3.98% | +$4.24M |
| Crinetics Pharmaceuticals In | 400,000 | 460,000 | +60,000 | $20.44M | $23.52M | 3.67% | +$3.08M |
| Nuvalent Inc | 337,500 | 285,000 | -52,500 | $34.53M | $22.31M | 3.49% | -$12.22M |
| Spyre Therapeutics, Inc.(SYRE) | 498,420 | 824,328 | +325,908 | $14.66M | $19.19M | 3.00% | +$4.53M |
| Wave Life Sciences, Inc.SHS(WVE) | 1,400,000 | 1,500,000 | +100,000 | $11.48M | $18.55M | 2.90% | +$7.08M |
| Centessa Pharmaceuticals PlcADS | 965,612 | 1,095,924 | +130,312 | $15.44M | $18.36M | 2.87% | +$2.92M |
| Vera Therapeutics, Inc.CL A(VERA) | 435,000 | 425,000 | -10,000 | $19.23M | $17.97M | 2.81% | -$1.25M |
| Nurix Therapeutics, Inc.(NRIX) | 860,399 | 940,083 | +79,684 | $19.33M | $17.71M | 2.77% | -$1.62M |
| Merus N V | 161,741 | 389,241 | +227,500 | $8.08M | $16.37M | 2.56% | +$8.29M |
| Coherus Oncology, Inc.NOTE 1 500 4 1(CHRS) | 0 | 0 | 0 | $13.05M | $16.19M | 2.53% | +$3.14M |
| Omeros CorpNOTE 5 250 2 1 | 0 | 0 | 0 | $14.64M | $14.61M | 2.28% | -$22.0K |
| Establishment Labs Holdings Inc.(ESTA) | 290,447 | 279,445 | -11,002 | $12.57M | $12.87M | 2.01% | +$306.4K |
| Arvinas, Inc.(ARVN) | 225,000 | 630,000 | +405,000 | $5.54M | $12.08M | 1.89% | +$6.54M |
| Karyopharm Therapeutics IncNOTE 3 000 10 1 | 0 | 0 | 0 | $9.62M | $11.87M | 1.85% | +$2.25M |
| Inozyme Pharma Inc | 2,822,318 | 3,972,318 | +1,150,000 | $14.76M | $11.00M | 1.72% | -$3.76M |
| Newamsterdam Pharma Company ORDINARY SHARES | 472,390 | 425,000 | -47,390 | $7.84M | $10.92M | 1.71% | +$3.08M |
| Autolus Therapeutics plcADS(AUTL) | 4,500,000 | 4,500,000 | 0 | $16.34M | $10.57M | 1.65% | -$5.76M |
| Geron Corporation(GERN) | 1,500,000 | 2,250,000 | +750,000 | $6.81M | $7.96M | 1.24% | +$1.16M |
| Rezolute, Inc.(RZLT) | 1,700,000 | 1,575,000 | -125,000 | $8.24M | $7.72M | 1.21% | -$527.5K |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 0 | 2,825,000 | +2,825,000 | $0 | $7.49M | 1.17% | +$7.49M |
| Oruka Therapeutics, Inc.(ORKA) | 349,836 | 368,698 | +18,862 | $8.57M | $7.15M | 1.12% | -$1.43M |
| Axsome Therapeutics, Inc.(AXSM) | 80,000 | 75,000 | -5,000 | $7.19M | $6.35M | 0.99% | -$843.9K |
| Erasca, Inc.(ERAS) | 2,499,431 | 2,499,431 | 0 | $6.82M | $6.27M | 0.98% | -$549.9K |
| Soleno Therapeutics Inc | 25,000 | 130,000 | +105,000 | $1.26M | $5.84M | 0.91% | +$4.58M |
| Travere Therapeutics, Inc.NOTE 2 250 3 0(TVTX) | 0 | 0 | 0 | $4.32M | $5.74M | 0.90% | +$1.42M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 325,000 | 300,000 | -25,000 | $6.30M | $5.64M | 0.88% | -$655.3K |
| BridgeBio Pharma, Inc.(BBIO) | 300,000 | 200,000 | -100,000 | $7.64M | $5.49M | 0.86% | -$2.15M |
| Protagonist Therapeutics Inc | 0 | 130,000 | +130,000 | $0 | $5.02M | 0.78% | +$5.02M |
| Mineralys Therapeutics, Inc.(MLYS) | 350,000 | 350,000 | 0 | $4.24M | $4.31M | 0.67% | +$70.0K |
| Perspective Therapeutics, Inc.(CATX) | 500,000 | 1,300,000 | +800,000 | $6.67M | $4.15M | 0.65% | -$2.53M |
| Avalo Therapeutics, Inc.(AVTX) | 45,000 | 550,765 | +505,765 | $425.7K | $4.09M | 0.64% | +$3.67M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 350,000 | 350,000 | 0 | $3.51M | $3.56M | 0.56% | +$52.5K |
| Travere Therapeutics, Inc.(TVTX) | 0 | 200,000 | +200,000 | $0 | $3.48M | 0.54% | +$3.48M |
| Insmed Incorporated(INSM) | 50,000 | 50,000 | 0 | $3.65M | $3.45M | 0.54% | -$198.0K |
| Newamsterdam Pharma CompanyW EXP 99 99 999 *W EXP 99/99/999 | 212,974 | 237,935 | +24,961 | $1.49M | $3.33M | 0.52% | +$1.84M |
| COMPASS Pathways plcADS(CMPS) | 300,512 | 850,512 | +550,000 | $1.89M | $3.21M | 0.50% | +$1.32M |
| Cullinan Therapeutics, Inc.(CGEM) | 263,817 | 263,817 | 0 | $4.42M | $3.21M | 0.50% | -$1.20M |
| Viridian Therapeutics, Inc.(VRDN) | 525,000 | 159,614 | -365,386 | $11.94M | $3.06M | 0.48% | -$8.88M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 75,000 | 70,742 | -4,258 | $2.92M | $2.93M | 0.46% | +$182 |
| CG Oncology, Inc.(CGON) | 0 | 100,000 | +100,000 | $0 | $2.87M | 0.45% | +$2.87M |
| Tectonic Therapeutic, Inc.(TECX) | 58,331 | 58,331 | 0 | $1.77M | $2.69M | 0.42% | +$925.7K |
| Helix Acquisition Corp IiCL A | 250,000 | 250,000 | 0 | $2.61M | $2.63M | 0.41% | +$12.5K |
| Oaktree Acquisition Corp IiiUNIT 10 04 2029 UNIT 10/04/2029 | 0 | 250,000 | +250,000 | $0 | $2.54M | 0.40% | +$2.54M |
| Immunovant, Inc.(IMVT) | 225,000 | 100,000 | -125,000 | $6.41M | $2.48M | 0.39% | -$3.94M |
| Aerovate Therapeutics Inc | 600,000 | 800,000 | +200,000 | $1.25M | $2.12M | 0.33% | +$866.0K |
| Vaxcyte, Inc.(PCVX) | 50,000 | 25,000 | -25,000 | $5.71M | $2.05M | 0.32% | -$3.67M |
| Nkarta, Inc.(NKTX) | 650,000 | 800,000 | +150,000 | $2.94M | $1.99M | 0.31% | -$946.0K |
| Nextcure Inc | 2,302,598 | 2,302,598 | 0 | $3.15M | $1.78M | 0.28% | -$1.38M |
| Anteris Technologies Global Corp.(AVR) | 0 | 300,000 | +300,000 | $0 | $1.67M | 0.26% | +$1.67M |
| Kymera Therapeutics, Inc.(KYMR) | 0 | 40,000 | +40,000 | $0 | $1.61M | 0.25% | +$1.61M |
| Apellis Pharmaceuticals Inc COM | 0 | 50,000 | +50,000 | $0 | $1.60M | 0.25% | +$1.60M |
| Rapt Therapeutics Inc | 0 | 1,000,000 | +1,000,000 | $0 | $1.58M | 0.25% | +$1.58M |
| Inari Med Inc | 60,000 | 25,000 | -35,000 | $2.47M | $1.28M | 0.20% | -$1.20M |
| Savara Inc.(SVRA) | 700,000 | 410,586 | -289,414 | $2.97M | $1.26M | 0.20% | -$1.71M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 0 | 144,159 | +144,159 | $0 | $1.24M | 0.19% | +$1.24M |
| Black Diamond Therapeutics I | 0 | 559,163 | +559,163 | $0 | $1.20M | 0.19% | +$1.20M |
| Context Therapeutics Inc.(CNTX) | 1,321,153 | 1,015,340 | -305,813 | $2.59M | $1.07M | 0.17% | -$1.52M |
| Kezar Life Sciences Inc COM NEW | 0 | 142,316 | +142,316 | $0 | $956.4K | 0.15% | +$956.4K |
| Climb Bio, Inc.(CLYM) | 1,500,000 | 500,000 | -1,000,000 | $7.63M | $900.0K | 0.14% | -$6.74M |
| Radiopharm Theranostics LimitedADS(RADX) | 0 | 156,171 | +156,171 | $0 | $684.0K | 0.11% | +$684.0K |
| Zura Bio LimitedCL A(ZURA) | 223,335 | 223,335 | 0 | $906.7K | $558.3K | 0.09% | -$348.4K |
| Celldex Therapeutics, Inc.(CLDX) | 125,000 | 9,992 | -115,008 | $4.25M | $252.5K | 0.04% | -$4.00M |
| Adagio Medical Holdings, Inc.(ADGM) | 213,235 | 213,235 | 0 | $550.1K | $223.9K | 0.03% | -$326.2K |
| Repare Therapeutics Inc | 173,351 | 100,000 | -73,351 | $596.3K | $131.0K | 0.02% | -$465.3K |
| Omeros Corporation(OMER) | 0 | 9,958 | +9,958 | $0 | $98.4K | 0.02% | +$98.4K |
| Q32 Bio Inc.(QTTB) | 27,777 | 27,777 | 0 | $1.24M | $95.6K | 0.01% | -$1.14M |
| Immatics N.VW EXP 07 01 202 | 187,204 | 187,204 | 0 | $430.6K | $47.1K | 0.01% | -$383.5K |
| Syros Pharmaceuticals Inc | 0 | 150,000 | +150,000 | $0 | $34.5K | 0.01% | +$34.5K |
| Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT) | 75,000 | 75,000 | 0 | $5.3K | $2.6K | 0.00% | -$2.7K |
| Whitehawk Therapeutics, Inc.(WHWK) | 47,019 | 0 | -47,019 | $96.9K | $0 | — | -$96.9K |
| Astria Therapeutics Inc | 725,106 | 0 | -725,106 | $7.98M | $0 | — | -$7.98M |
| BeOne Medicines AGADR(ONC) | 35,000 | 0 | -35,000 | $7.86M | $0 | — | -$7.86M |
| BioMarin Pharmaceutical Inc.(BMRN) | 15,000 | 0 | -15,000 | $1.05M | $0 | — | -$1.05M |
| Genelux Corporation(GNLX) | 100,000 | 0 | -100,000 | $237.0K | $0 | — | -$237.0K |
| Immatics N.V.SHS(IMTX) | 250,000 | 0 | -250,000 | $2.85M | $0 | — | -$2.85M |
| Kezar Life Sciences Inc | 2,511,778 | 0 | -2,511,778 | $1.94M | $0 | — | -$1.94M |
| Kura Oncology, Inc.(KURA) | 687,785 | 0 | -687,785 | $13.44M | $0 | — | -$13.44M |
| Kyverna Therapeutics, Inc.(KYTX) | 119,900 | 0 | -119,900 | $586.3K | $0 | — | -$586.3K |
| Neurobo Pharmaceuticals In | 89,222 | 0 | -89,222 | $282.8K | $0 | — | -$282.8K |
| Promis Neurosciences Inc | 30,643 | 0 | -30,643 | $38.3K | $0 | — | -$38.3K |
| Puma Biotechnology, Inc.(PBYI) | 250,000 | 0 | -250,000 | $637.5K | $0 | — | -$637.5K |
| Roivant Sciences Ltd.SHS(ROIV) | 201,587 | 0 | -201,587 | $2.33M | $0 | — | -$2.33M |
| Springworks Therapeutics Inc | 147,500 | 0 | -147,500 | $4.73M | $0 | — | -$4.73M |
| Terns Pharmaceuticals Inc | 600,000 | 0 | -600,000 | $5.00M | $0 | — | -$5.00M |
| Verastem, Inc.(VSTM) | 400,000 | 0 | -400,000 | $1.20M | $0 | — | -$1.20M |
| Voyager Therapeutics, Inc.(VYGR) | 51,727 | 0 | -51,727 | $302.6K | $0 | — | -$302.6K |